• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lyell Immunopharma Inc (NQ: LYEL )

    1.305 -0.735 (-36.03%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 11,875,410
    Open 1.690
    Bid (Size) 1.340 (1)
    Ask (Size) 1.390 (4)
    Prev. Close 2.040
    Today's Range 1.250 - 1.700
    52wk Range 1.250 - 3.410
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Lyell Immunopharma Shares Plunge On One Patient Death In CAR-T Cell Therapy Cancer Trial
    Lyell Immunopharma shares fell following the release of initial clinical data from its Phase 1 trial of LYL797, a reprogrammed CAR T-cell product. The company reported some severe cases reported in... 
    Via Benzinga
    Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology
    From Lyell Immunopharma, Inc
    Via GlobeNewswire

    Performance

    YTD
    -38.15%
    -38.15%
    1 Month
    -52.55%
    -52.55%
    3 Month
    -32.73%
    -32.73%
    6 Month
    -38.73%
    -38.73%
    1 Year
    -59.22%
    -59.22%

    More News

    Read More
    Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Why Lyell Immunopharma Shares Are Rising Today
    Via Benzinga
    Lyell Immunopharma to Participate in BofA Securities Health Care Conference
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    LYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q1 2024
    Via InvestorPlace
    Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Lyell Immunopharma Announces Participation in March Investor Conferences
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
    From Lyell Immunopharma, Inc
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.